Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.

Eedara BB, Veerareddy PR, Jukanti R, Bandari S.

Drug Dev Ind Pharm. 2014 Aug;40(8):1030-43. doi: 10.3109/03639045.2013.801984. Epub 2013 Jun 5.

PMID:
23738504
2.

Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.

Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H.

Int J Pharm. 2014 Apr 25;465(1-2):306-16. doi: 10.1016/j.ijpharm.2014.01.023. Epub 2014 Jan 20.

PMID:
24456672
3.

Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.

Lee JY, Kang WS, Piao J, Yoon IS, Kim DD, Cho HJ.

Drug Des Devel Ther. 2015 May 22;9:2745-56. doi: 10.2147/DDDT.S84070. eCollection 2015.

4.

Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.

Ji H, Tang J, Li M, Ren J, Zheng N, Wu L.

Drug Deliv. 2016;23(2):459-70. doi: 10.3109/10717544.2014.918677. Epub 2014 Jun 3.

PMID:
24892628
5.

Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.

Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L.

Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):413-22. doi: 10.1007/s13318-015-0265-6. Epub 2015 Feb 11.

PMID:
25669445
6.

Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.

Moneghini M, De Zordi N, Solinas D, Macchiavelli S, Princivalle F.

Future Med Chem. 2010 Feb;2(2):237-46. doi: 10.4155/fmc.09.166.

PMID:
21426191
7.

Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.

Chella N, Daravath B, Kumar D, Tadikonda RR.

Eur J Drug Metab Pharmacokinet. 2016 Oct;41(5):517-26. doi: 10.1007/s13318-015-0290-5.

PMID:
26156887
8.
9.

Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.

Kim DS, Kim DW, Kim KS, Choi JS, Seo YG, Youn YS, Oh KT, Yong CS, Kim JO, Jin SG, Choi HG.

Colloids Surf B Biointerfaces. 2016 Nov 1;147:250-7. doi: 10.1016/j.colsurfb.2016.08.010. Epub 2016 Aug 8.

PMID:
27518457
10.

Fast-dissolving and high-drug-loaded, Fatty Acid-based self-emulsifying solid dispersions of diacerein.

Aggarwal AK, Singh S.

PDA J Pharm Sci Technol. 2012 May-Jun;66(3):201-13. doi: 10.5731/pdajpst.2012.00857.

PMID:
22634586
11.
12.

Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.

Zhaojie M, Ming Z, Shengnan W, Xiaojia B, Hatch GM, Jingkai G, Li C.

Int J Pharm. 2014 Jun 5;467(1-2):50-9. doi: 10.1016/j.ijpharm.2014.03.017. Epub 2014 Mar 5.

PMID:
24607213
13.
14.

Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.

Khan S, Batchelor H, Hanson P, Perrie Y, Mohammed AR.

J Pharm Sci. 2011 Oct;100(10):4281-94. doi: 10.1002/jps.22613. Epub 2011 May 10.

PMID:
21560130
15.

Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.

Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J.

Drug Dev Ind Pharm. 2015 May;41(5):772-9. doi: 10.3109/03639045.2014.902466. Epub 2014 Mar 26.

PMID:
24669978
16.

In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate.

Gundogdu E, Mangas-Sanjuan V, Gonzalez-Alvarez I, Bermejo M, Karasulu E.

Eur J Drug Metab Pharmacokinet. 2012 Mar;37(1):65-75. doi: 10.1007/s13318-011-0059-4. Epub 2011 Aug 11.

PMID:
21833762
17.

Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.

Ha ES, Kim JS, Baek IH, Yoo JW, Jung Y, Moon HR, Kim MS.

Drug Des Devel Ther. 2015 Aug 4;9:4269-77. doi: 10.2147/DDDT.S90706. eCollection 2015.

19.

Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.

Dhumal RS, Biradar SV, Aher S, Paradkar AR.

J Pharm Pharmacol. 2009 Jun;61(6):743-51. doi: 10.1211/jpp.61.06.0006.

PMID:
19505364
20.

Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.

Kumar BS, Saraswathi R, Kumar KV, Jha SK, Venkates DP, Dhanaraj SA.

Drug Deliv. 2014 May;21(3):173-84. doi: 10.3109/10717544.2013.840690. Epub 2013 Oct 9.

PMID:
24102185

Supplemental Content

Support Center